Neurocrine Biosciences, Inc. (NBIX)
Neurocrine Biosciences (NBIX) sees significant social media buzz with engagements up over 3000% following a week of increased mentions and creator activity. The company entered the top [--] AltRank™ for the first time, indicating a surge in overall interest.
About Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on treatments for neurological and endocrine-related disorders.
Neurocrine Biosciences, Inc. uses the ticker $NBIX for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Neurocrine Biosciences, Inc. (NBIX) trading volume is up 79.59% from the previous week.
- Neurocrine Biosciences, Inc. (NBIX) social dominance is up 525% from the previous week.
- Neurocrine Biosciences, Inc. (NBIX) creators is up 70.42% from the previous week.
- Neurocrine Biosciences, Inc. (NBIX) engagements is up 3528.94% from the previous week.
- Neurocrine Biosciences, Inc. (NBIX) mentions is up 110.06% from the previous week.
- Neurocrine Biosciences, Inc. (NBIX) posts created is up 587.5% from the previous week.
- Neurocrine Biosciences, Inc. entered the top [--] AltRank™ for the first time
Price: $124.10
Price 24-Hour Time-Series Raw Data
The stock price experienced a minor dip of -1.92% in the last [--] hours, primarily due to missed EPS estimates and the failure of the KINECT-DCP study, despite strong INGREZZA sales and positive analyst sentiment.
24-Hour: 0.23% 7-Day: -11.06% 30-Day: -6.25%
1-Year High: $155.60 on 2025-12-10
1-Year Low: $87.50 on 2025-04-08
AltRank: [-----]
AltRank 24-Hour Time-Series Raw Data
Neurocrine Biosciences, Inc. (NBIX) is currently AltRank #1,164 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [-----] [----]
[--] Month: [-----] +619
[--] Months: [-----] +419
[--] Year: [-----] +545
1-Year High: [-----] on 2026-02-01
1-Year Low: [--] on 2025-07-12
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +5
[--] Months: [--] +14
[--] Year: [--] [---]
1-Year High: [--] on 2025-07-02
1-Year Low: [--] on 2025-09-24
Engagements: [---] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [-----]
[--] Week: [-------] +3,529%
[--] Month: [-------] +106%
[--] Months: [---------] -57%
[--] Year: [---------] -2.90%
1-Year High: [-------] on 2025-05-05
1-Year Low: [---] on 2026-02-01
Engagements by network (24h): YouTube: [--] Reddit: [--] News: [--] TikTok: [--] X: [---]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [---]
[--] Week: [---] +110%
[--] Month: [---] +16%
[--] Months: [-----] -86%
[--] Year: [------] +259%
1-Year High: [-----] on 2025-07-03
1-Year Low: [--] on 2025-12-07
Mentions by network (24h): YouTube: [--] Reddit: [--] News: [--] TikTok: [--] X: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Neurocrine Biosciences, Inc. (NBIX) in the last [--] hours which is up 14% from [--] in the previous [--] hours
Daily Average: [---]
[--] Week: [---] +70%
[--] Month: [---] -8%
[--] Months: [---] -93%
[--] Year: [------] +700%
1-Year High: [-----] on 2025-07-03
1-Year Low: [--] on 2025-12-07
The most influential creators that mention Neurocrine Biosciences, Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Andre_AGTC | [--] | [-----] | [--] | [---] |
| @OracleEarnings | [--] | [------] | [--] | [---] |
| @BuyTheUgly | [--] | [--] | [--] | [--] |
| @MarcJacksonLA | [--] | [-----] | [--] | [--] |
| @AIStockSavvy | [--] | [------] | [--] | [--] |
| @neurocrinebiosciencesinc | [--] | [--] | [--] | [--] |
| @mariostario2019 | [--] | [--] | [--] | [--] |
| @moneyforfun_ | [--] | [---] | [--] | [--] |
Sentiment: 83%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 83%
Daily Average: 67%
[--] Week: 88% -12%
[--] Month: 88% +27%
[--] Months: 88% +6%
[--] Year: 88% +30%
1-Year High: 100% on 2025-07-20
1-Year Low: 25% on 2025-09-15
Most Supportive Themes:
- Ingrezza Sales Growth: (40%) Ingrezza sales are increasing market penetration and revenue.
- Crenessity Phase [--] Study: (35%) Positive outcomes from the Crenessity Phase [--] study boost confidence in Neurocrine's pipeline.
- Affordable Growth Potential: (25%) Mentions in 'Affordable Growth' screens highlight the potential for long-term value.
Most Critical Themes:
- Missed EPS Estimates: (5%) Missed EPS estimates may cause short-term volatility.
Social Dominance: 0.00444%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00444%
Daily Average: 0.02%
[--] Week: 0.013% +0.011%
[--] Month: 0.015% +0.0072%
[--] Months: 0.015% -0.003%
[--] Year: 0.015% -0.013%
1-Year High: 0.211% on 2025-07-03
1-Year Low: 0.0021% on 2025-12-07
Market Dominance: 0.014%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.014%
Daily Average: 0%
1-Year High: 0.389% on 2025-04-09
1-Year Low: 0.014% on 2026-02-16
Market Cap: $12,445,069,412
Market Cap 24-Hour Time-Series Raw Data
Current Value: $12,445,069,412
Daily Average: $13,018,173,701
[--] Week: $12,445,069,412 -11%
[--] Month: $12,457,113,028 -5.60%
[--] Months: $12,457,113,028 -5.70%
[--] Year: $12,457,113,028 +8.60%
1-Year High: $15,517,197,780 on 2025-12-10
1-Year Low: $8,990,517,324 on 2025-04-12
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing